Kassie Harrold

Chief Compliance Officer, Keenova Therapeutics plc.

Companies

Keenova Therapeutics plcChief Compliance Officer Mar 8, 2021 to Jan 2, 2025¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Keenova Therapeutics plc863 shares²Jan 1, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

Jan 1, 2025Shares withheld for tax 846 shares of Keenova Therapeutics plc²
Jan 1, 2025Exercised options 1,709 shares of Keenova Therapeutics plc²
Nov 14, 2023Returned to company 32,000 shares of Keenova Therapeutics plc³
Aug 17, 2023Shares withheld for tax 5,545 shares at $0.69 of Keenova Therapeutics plc⁴
Dec 14, 2022Granted 37,545 shares of Keenova Therapeutics plc⁵
Jun 16, 2022Returned to company 118 shares of Keenova Therapeutics plc⁶

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARKeenova Therapeutics plc, Chief Compliance Officer
2
SEC EDGARKeenova Therapeutics plc shares after the filing of Jan 1, 2025
3
SEC EDGARForm 4 filed Nov 16, 2023
4
SEC EDGARForm 4 filed Aug 18, 2023
5
SEC EDGARForm 4 filed Dec 22, 2022
6
SEC EDGARForm 4 filed Jun 21, 2022